Skip to content

Investigating the effect of electromagnetism in reducing knee osteoarthritis symptoms

Investigating the effectiveness of electromagnetic therapy on improving the symptoms of second and third degree knee osteoarthritis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20231007059642N1
Enrollment
60
Registered
2023-10-22
Start date
2023-10-23
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis. Osteoarthritis of knee

Interventions

Intervention 1: Intervention group: In this group, drug treatment with 1 tablet of meloxicam 15mg once a day for 18 days and exercise therapy 3 times a day for 18 days, each for 20 seconds and 3 times

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: Primary diagnosis of grade 2 and 3 OA based on ACR criteria, including radiological evidence, clinical examination and history Age =40 years The presence of dry knee symptoms and frequent daily pain since 6 months ago Symptomatic illness from at least 6 months ago Presence of pain with VAS =3 criteria

Exclusion criteria

Exclusion criteria: Intra-articular drug administration in the last 6 months Systemic treatment with corticosteroids or physical therapy in the last 6 weeks Cartilaginous consumption in the last 6 weeks Back radicular pains Knee pain caused by malignant, autoimmune and inflammatory pathology or caused by knee deformities such as genovarus and genovalgus etc. Patients who have a history of knee surgery Lack of cooperation and difficulty in referring and following the intervention process pregnancy Metal implant like heart pacemaker

Design outcomes

Primary

MeasureTime frame
Symptoms of knee osteoarthritis. Timepoint: before, immediately and 6 weeks and 3 months after the end of the treatment. Method of measurement: Visual Analogue Scale and Western Ontario and McMaster Universities Osteoarthritis Index scale.

Secondary

MeasureTime frame
Average pain intensity. Timepoint: Before, immediately and 6 weeks and 3 months after the end of the treatment. Method of measurement: Visual Analogue Scale.;Physical performance. Timepoint: Before, immediately and 6 weeks and 3 months after the end of the treatment. Method of measurement: Western Ontario and McMaster Universities Osteoarthritis Index.;Joint dryness. Timepoint: Before, immediately and 6 weeks and 3 months after the end of the treatment. Method of measurement: Western Ontario and McMaster Universities Osteoarthritis Index.;Range of motion. Timepoint: Before, immediately and 6 weeks and 3 months after the end of the treatment. Method of measurement: Western Ontario and McMaster Universities Osteoarthritis Index.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSaeideh Safinataj

Esfahan University of Medical Sciences

saeide.safi@gmail.com+98 913 347 5411

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026